Navigation Links
Quorum Review’s CEO Presents on IRB Response to Key Changes in Clinical Research Practice
Date:5/14/2013

Seattle, WA (PRWEB) May 14, 2013

Quorum Review IRB, the industry leader in central IRB services, announces CEO Cami Gearhart, JD, as a presenter at the inaugural Forum on Optimizing Clinical Research Performance. The conference will be held in Boston, MA, May 19-21, 2013.

Ms. Gearhart will present on “IRB Response to Key Changes in Clinical Research Practice,” focusing on current issues such as biorepositories, utilization of central IRBs, social media and emerging e-consent tools. The presentation will take place Monday, May 20th at 4:45 p.m.-5:10 p.m.

Ms. Gearhart originally joined Quorum Review as a member of the IRB, and was appointed CEO in 2006. She has led the Quorum business through two AAHRPP accreditations and a successful expansion into Canada. Prior to joining Quorum Review, Ms. Gearhart practiced law in both the private sector, specializing in health care regulatory law for hospitals, clinics and other institutions, and the public sector, working for the Office of Attorney General protecting vulnerable populations. Ms. Gearhart also serves as Treasurer of the Consortium of Institutional Review Boards and Vice President for the Northwest Association for Biomedical Research’s Board of Directors.

The Forum on Optimizing Clinical Research Performance is being presented through a new strategic alliance between CenterWatch and iiBIG. This year marks the inauguration of the one-of-a-kind, strategic leadership forum that brings together sponsors, CROs, sites and other organizations. The conference provides high-quality, relevant content to all clinical research professionals. More information about the conference is available on the iiBIG website.

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10718574.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quorum Review IRB Launches Site Enrollment Service
2. Quorum Review IRB Presents “IRB Review of Registries, Databases and Biobanking” at 2013 AAHRPP Conference
3. Quorum Review IRB to Present “eConsent and the iPad: a Case Study” at Global ACRP Conference
4. Quorum Review IRB Presents on Good Clinical Practice Essentials at MAGI’s 2013 Clinical Research Conference
5. Fitness Revolution Honored as Top Fitness Franchise in Franchise Business Review’s Franchisee Satisfaction Awards
6. Fitness Revolution Receives Franchise Business Review’s Best in Fitness Franchisee Satisfaction Award
7. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
8. Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO
9. AGA presents cutting-edge research during DDW®
10. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
11. Vygone Presents a Revolutionary Electro Waveform Device to Help Treat Molluscum Contagiosum Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: